EXABS-149-AML Is All Oral Therapy of AML a Reality for the Future?

Farhad Ravandi

doi:10.1016/S2152-2650(22)00661-9

EXABS-149-AML Is All Oral Therapy of AML a Reality for the Future?

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S58
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	22
DOIs	https://doi.org/10.1016/S2152-2650(22)00661-9
State	Published - Oct 2022
Externally published	Yes

Keywords

AML

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/S2152-2650(22)00661-9

Cite this

@article{0162e063b11049bdaa9cc1b0f6a44112,

title = "EXABS-149-AML Is All Oral Therapy of AML a Reality for the Future?",

keywords = "AML",

author = "Farhad Ravandi",

year = "2022",

month = oct,

doi = "10.1016/S2152-2650(22)00661-9",

language = "English (US)",

volume = "22",

pages = "S58",

journal = "Clinical Lymphoma, Myeloma and Leukemia",